Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

1994 • 6,495 citations

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

1993 • 4,650 citations

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 • 3,484 citations

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

1999 • 3,357 citations

National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

1982 • 3,027 citations

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

1997 • 2,405 citations

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1998 • 1,216 citations

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

1982 • 987 citations

Patient preferences for oral versus intravenous palliative chemotherapy.

1997 • 922 citations

Molecular Cloning of the Chromosomal Breakpoint of B-Cell Lymphomas and Leukemias with the t(11;14) Chromosome Translocation

1984 • 671 citations

Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.

1996 • 535 citations

Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data

1992 • 519 citations

Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11 ; 14) chromosome translocation

1985 • 446 citations

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

1998 • 408 citations

A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study

1995 • 352 citations

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

1993 • 333 citations

Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts

1998 • 330 citations

Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.

1997 • 261 citations

Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia

2000 • 258 citations

Flavopiridol Induces Apoptosis of Normal Lymphoid Cells, Causes Immunosuppression, and Has Potent Antitumor Activity In Vivo Against Human Leukemia and Lymphoma Xenografts

1998 • 246 citations

Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases

1981 • 238 citations

Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol

1998 • 225 citations

The Novel Cyclin-Dependent Kinase Inhibitor Flavopiridol Downregulates Bcl-2 and Induces Growth Arrest and Apoptosis in Chronic B-Cell Leukemia Lines

1997 • 197 citations

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.

1995 • 196 citations

Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma

1995 • 194 citations

Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia

2000 • 193 citations

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.

1994 • 191 citations

Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells.

1996 • 190 citations

Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period

1995 • 176 citations

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

1989 • 175 citations

Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.

1999 • 172 citations

Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

2000 • 160 citations

Phase I Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination With Paclitaxel in Patients With Advanced Solid Tumors

2002 • 159 citations

Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.

1995 • 156 citations

Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors

2001 • 152 citations

Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes.

1999 • 146 citations

A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug

1999 • 118 citations

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

1999 • 116 citations

Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts.

2001 • 114 citations

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

1994 • 110 citations

Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit.

2001 • 108 citations

Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells

1998 • 102 citations

Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors.

1999 • 100 citations

Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

2001 • 99 citations

A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients

2001 • 99 citations

Phase II Trial of Weekly IV Vinorelbine as a Single Agent in First-Line Advanced Breast Cancer Chemotherapy

1995 • 78 citations

Seventy-Two Hour Continuous Infusion Flavopiridol in Relapsed and Refractory Mantle Cell Lymphoma

2002 • 78 citations

Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients

1998 • 74 citations

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer

1994 • 72 citations

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.

1994 • 64 citations

Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic, Immunophenotypic, and Prognostic Factors

1990 • 64 citations

Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials

2002 • 59 citations

Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II study

1996 • 57 citations

Vinorelbine and Paclitaxel as First-Line Chemotherapy in Metastatic Breast Cancer

1999 • 55 citations

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

1999 • 54 citations

Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol

2002 • 50 citations

Oral vinorelbine: Feasibility and safety profile

2001 • 47 citations

Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.

1995 • 44 citations

Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC)

2001 • 41 citations

The effects of food on the pharmacokinetic profile of oral vinorelbine

2002 • 39 citations

Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.

1995 • 29 citations

Rational Design of New Tumoractivated<sup>TM</sup> Cytotoxic Agents

1999 • 27 citations

A pharmacological study of the weekday-on/weekend-off oral UFT schedule in colorectal cancer patients

2001 • 22 citations